Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Oliver Tobin

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
Clinical and Translational Radiation Oncology|May 6, 2026
Impact of modern central nervous system radiation on multiple sclerosis relapse and progressionHannah H Zhao-Fleming, Daniel K Ebner, William Sperduto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2019
Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-upAxel Petzold, Mark Woodhall, Z Khaleeli, et al.
Multiple Sclerosis and Related Disorders|April 5, 2023
ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosisCaitlin Jackson-Tarlton, Diana Londoño, Claudia F Lucchinetti, et al.
Neurology|August 6, 2024
Intra-arterial Melphalan as Targeted Therapy for Tumefactive Multiple Sclerosis LesionsSamantha A Banks, Waleed Brinjikji, Caterina Giannini, et al.
JAMA Ophthalmology|February 23, 2018
Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment TrialJohn J Chen, W Oliver Tobin, Masoud Majed, et al.
Multiple Sclerosis and Related Disorders|March 22, 2023
Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosisCaitlin S Jackson-Tarlton, B Mark Keegan, Mahboubeh Fereidan-Esfahani, et al.
Brain : a Journal of Neurology|October 21, 2017
Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)W Oliver Tobin, Yong Guo, Karl N Krecke, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|August 2, 2021
Harry Lee Parker: Games Lost and Won on the Playing Fields of NeurologyChristopher J Boes, James P Klaas, W Oliver Tobin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 2, 2021
Long-term clinical, MRI, and cognitive follow-up in a large cohort of pathologically confirmed, predominantly tumefactive multiple sclerosisAlicja Kalinowska-Lyszczarz, Jan-Mendelt Tillema, W Oliver Tobin, et al.
Multiple Sclerosis and Related Disorders|June 10, 2026
A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndromeAlbert Aboseif, Nur Neyal, B Mark Keegan, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Clinical and Translational Radiation Oncology|May 6, 2026
Impact of modern central nervous system radiation on multiple sclerosis relapse and progressionHannah H Zhao-Fleming, Daniel K Ebner, William Sperduto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2019
Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-upAxel Petzold, Mark Woodhall, Z Khaleeli, et al.
Multiple Sclerosis and Related Disorders|April 5, 2023
ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosisCaitlin Jackson-Tarlton, Diana Londoño, Claudia F Lucchinetti, et al.
Neurology|August 6, 2024
Intra-arterial Melphalan as Targeted Therapy for Tumefactive Multiple Sclerosis LesionsSamantha A Banks, Waleed Brinjikji, Caterina Giannini, et al.
JAMA Ophthalmology|February 23, 2018
Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment TrialJohn J Chen, W Oliver Tobin, Masoud Majed, et al.
Multiple Sclerosis and Related Disorders|March 22, 2023
Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosisCaitlin S Jackson-Tarlton, B Mark Keegan, Mahboubeh Fereidan-Esfahani, et al.
Brain : a Journal of Neurology|October 21, 2017
Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)W Oliver Tobin, Yong Guo, Karl N Krecke, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|August 2, 2021
Harry Lee Parker: Games Lost and Won on the Playing Fields of NeurologyChristopher J Boes, James P Klaas, W Oliver Tobin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 2, 2021
Long-term clinical, MRI, and cognitive follow-up in a large cohort of pathologically confirmed, predominantly tumefactive multiple sclerosisAlicja Kalinowska-Lyszczarz, Jan-Mendelt Tillema, W Oliver Tobin, et al.
Multiple Sclerosis and Related Disorders|June 10, 2026
A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndromeAlbert Aboseif, Nur Neyal, B Mark Keegan, et al.
Pageof 13